carbamylhydrazine has been researched along with Idiopathic Parkinson Disease in 2 studies
carbamylhydrazine: RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palfreyman, MG | 1 |
| McDonald, IA | 1 |
| Bey, P | 1 |
| Danzin, C | 1 |
| Zreika, M | 1 |
| Cremer, G | 1 |
| Maruyama, W | 1 |
| Naoi, M | 1 |
| Kasamatsu, T | 1 |
| Hashizume, Y | 1 |
| Takahashi, T | 1 |
| Kohda, K | 1 |
| Dostert, P | 1 |
1 trial available for carbamylhydrazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential.
Topics: Allyl Compounds; Amine Oxidase (Copper-Containing); Animals; Butylamines; Drug Evaluation; Humans; M | 1994 |
1 other study available for carbamylhydrazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Apoptosis; Carcinogens; Catalase; Cycloheximide; DNA Damage; Dopamine; Free Radicals; | 1997 |